Genocea Biosciences

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch GNCA and buy or sell other stocks, options, and ETFs commission-free!

About GNCA

Genocea Biosciences, Inc. engages in the development and commercialization of cancer immunotherapies. The firm uses its proprietary technology platform, ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses. 

CEO
William D. Clark
CEOWilliam D. Clark
Employees
74
Employees74
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2006
Founded2006
Employees
74
Employees74

GNCA Key Statistics

Market cap
955.11K
Market cap955.11K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.14M
Average volume1.14M
High today
$0.0149
High today$0.0149
Low today
$0.012
Low today$0.012
Open price
$0.0145
Open price$0.0145
Volume
177.96K
Volume177.96K
52 Week high
$2.15
52 Week high$2.15
52 Week low
$0.008
52 Week low$0.008
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.